Instructional Course - Requires Course Pass, Additional Registration Required

Instructional Course

067IC - Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems

Monday, May 21
10:00 AM - 12:00 PM
Location: MCC WEST, 2006

This course will review the 2015 AUA practice guidelines for non-muscle-invasive bladder cancer and detail strategies to manage common clinical predicaments involved in the management of these tumors. Specifically we will review: the AUA guidelines; risk stratification and use of cystectomy; selection of the optimal intravesical agent at the right schedule; and treatment of toxicity from intravesical therapy. Practical solutions will be presented that can be readily integrated into the office setting. Emphasis is placed on the evaluation of real clinical cases with open audience participation.

Learning Objectives:

Kamal S. Pohar

The Ohio State University

Dr. Kamal Pohar completed his urology residency at the University of Manitoba and a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center. He joined the faculty at The Ohio State University in 2003 and is currently Associate Professor of Urology and holder of the Julius and Diana Skestos Endowed Chair in Urology. Dr. Pohar’s clinical practice is exclusively focused on the management and treatment of patients with bladder cancer. He runs a translational research lab that is focused on studying a family of transcription factors that modulate the tumor microenvironment during the various stages of bladder cancer development. His group is also actively participating in numerous national clinical trials as well as investigator initiated trials that are exploring the tumor microenvironment as a biomarker in bladder cancer.

Presentation(s):

Send Email for Kamal Pohar

Ashish M. Kamat

MD Anderson Cancer Center

Ashish M. Kamat is a Professor of Urology and Wayne B. Duddlesten Professor of Cancer Research at M.D. Anderson Cancer Center in Houston, TX . Dr He is a graduate of the AUA Leadership Program and Associate Cancer Center Director, RFHNH, Mumbai.

Dr. Kamat is a recognized expert in urologic oncology with an emphasis on bladder cancer, organ sparing and minimally invasive techniques. Dr Kamat maintains an active research portfolio in this area with a focus on efforts to develop novel therapies, and identifying predictors of response to therapy (e.g. intravesical immunotherapy), as a first step towards personalized cancer therapeutics. He has initiated, led, and been active in several large studies including multinational trials in bladder cancer; these findings have been published in high impact journals. He is a co-PI on the MD Anderson GU SPORE (Bladder). Dr Kamat is an exceptional educator, as Program Director grew the MD Anderson Urologic Oncology Fellowship into a top program in the US and been selected twice for the Robert M. Chamberlain Distinguished Mentor Award.

Dr Kamat has authored numerous editorials, book chapters, and over 245 publications in peer reviewed journals, and serves on the editorial board of high ranked journals. He is listed in 'Who's Who in Medicine' and ‘Best Doctors in America’ and has won the ‘Compassionate Doctor Award’ from patient groups. He is recognized internationally for his efforts and has been invited as a visiting professor to several universities; to deliver invited plenary sessions; to chair related committees eg: Society of Immunotherapy for Cancer (SITC); and as an AUA International Faculty.

Dr Kamat is President of the IBCN and IBCG, actively participates in various Global urologic efforts, serves on the board of societies (SCS AUA, Texas Urologic Society, SUO – CTC) and in patient advocacy groups such as BCAN.

Presentation(s):

Send Email for Ashish Kamat

Cheryl T. Lee

The Ohio State University

Dr. Lee is the Chair of the Department of Urology at The Ohio State University Wexner Medical Center where she holds the Dorothy M. Davis Endowed Chair in Cancer Research. Her medical professional focus is dedicated to improving the care of bladder cancer patients through advocacy, education and research. She has served the Bladder Cancer Advocacy Network as the President of the Scientific Advisory Board, as a current member of its Board of Directors, and as a Past-Chairman of the Bladder Cancer Think Tank. She is a recent member of the Board of Directors of the American Cancer Society, Lakeshore Division.

Dr. Lee is active in the education of urologists. She maintains a postgraduate course at the annual meeting of the AUA and has served on the ABU Oral Board Examination Committee, the AUA Update Editorial Board, the AUA Education Council, the AUA Program Committee, the American Board of Urology /AUA Examination Committee, and the Oncology Knowledge Assessment Test Committee of the Society of Urologic Oncology (SUO). She remains an active member of the SUO, and currently serves as the AJCC representative. She is a Past-President of the National Medical Association R. Frank Jones Urological Society. Her main research interest is the improvement of quality of life and survivorship for bladder cancer patients.

Presentation(s):

Send Email for Cheryl Lee

J. Alfred Witjes

radboud university medical center

Short biography Prof Dr. J.A.Witjes

Fred Witjes is professor in oncological urology. His research interest is translational and clinical research in bladder, prostate and testicular cancer.
He has many training and teaching activities. He is a member of several international societies, and he chairs, amongst others, the Dutch guidelines committee on bladder cancer and the EAU guidelines committee on metastatic and muscle-invasive bladder cancer. Since 2010 he is member of the European Urology Scolarship Program.
He is reviewer for many, and editor of several urological and oncological journals.
He is involved in and leads many studies and projects which has resulted in many lectures and almost 500 (peer reviewed) publications, reviews and bookchapters.

Presentation(s):

Send Email for J. Alfred Witjes


Assets

067IC - Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems